CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
86 hedge funds and large institutions have $98.3M invested in Cascadian Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 16
25% less capital invested
Capital invested by funds: $131M → $98.3M (-$32.9M)
Holders
86
Holding in Top 10
1
Calls
$972K
Puts
$158K
Top Buyers
| 1 | +$5.98M | |
| 2 | +$4.33M | |
| 3 | +$2.88M | |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$2.41M |
| 5 |
QF
QVT Financial
New York
|
+$2.07M |
Top Sellers
| 1 | -$7.72M | |
| 2 | -$1.07M | |
| 3 | -$596K | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$588K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$502K |